We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $11.1M

43% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 51

8% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 50

3% less funds holding

Funds holding: 200 → 195 (-5)

15.73% less ownership

Funds ownership: 132.15% → 116.42% (-16%)

33% less capital invested

Capital invested by funds: $2.27B → $1.51B (-$755M)

73% less funds holding in top 10

Funds holding in top 10: 11 → 3 (-8)

Holders
195
Holders Change
-5
Holders Change %
-2.5%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-72.73%
% of All Funds
0.04%
New
46
Increased
73
Reduced
51
Closed
50
Calls
$41.3M
Puts
$11.1M
Net Calls
+$30.2M
Net Calls Change
+$16.9M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
State Street
State Street
Massachusetts
+$45.7M
3
SL
Siren LLC
Connecticut
+$32.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
DFO
Duquesne Family Office
New York
+$22M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$28M
2
VPC
Vestal Point Capital
New York
-$27.2M
3
SC
Samlyn Capital
New York
-$26.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$23M
5
EAM
Eventide Asset Management
Massachusetts
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Optiver Holding
176
Optiver Holding
Netherlands
$4.93K -$178 -8 -2%
Osaic Holdings
177
Osaic Holdings
Arizona
$4.73K -$3.5K -157 -33%
JSAM
178
J. Safra Asset Management
New York
$4.07K +$6.08K +273 New
RIL
179
Rothschild Investment LLC
Illinois
$3.35K -$45 -2 -0.9%
FFA
180
Farther Finance Advisors
California
$2.72K – – –
PFBT
181
Parkside Financial Bank & Trust
Missouri
$2.01K – – –
SS
182
SBI Securities
Japan
$910 – – –
TWD
183
True Wealth Design
Ohio
$910 – – –
EWA
184
EverSource Wealth Advisors
Alabama
$820 -$26.5K -1,190 -96%
CA
185
Clearstead Advisors
Ohio
$567 -$111 -5 -12%
SAM
186
Smartleaf Asset Management
Massachusetts
$537 +$890 +40 New
HC
187
Hurley Capital
New York
$432 – – –
BFS
188
Bare Financial Services
Pennsylvania
$298 +$445 +20 New
HI
189
Harbour Investments
Wisconsin
$162 +$223 +10 New
IA
190
IFP Advisors
Florida
$89 – – –
LFG
191
Larson Financial Group
Missouri
$89 +$134 +6 New
MCM
192
MAI Capital Management
Ohio
$75 +$111 +5 New
HNB
193
Huntington National Bank
Ohio
$15 – – –
AWM
194
Activest Wealth Management
Florida
$13 – – –
SC
195
Samlyn Capital
New York
– -$26.7M -1,069,543 Closed
EAM
196
Eventide Asset Management
Massachusetts
– -$14.2M -569,000 Closed
Holocene Advisors
197
Holocene Advisors
New York
– -$12.7M -506,001 Closed
Marshall Wace
198
Marshall Wace
United Kingdom
– -$9.01M -360,394 Closed
Skandinaviska Enskilda Banken (SEB)
199
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$7.04M -281,687 Closed
CCM
200
Catalio Capital Management
New York
– -$6.68M -267,058 Closed
6 7
8
9 10

OLMA Hedge Fund Activity: Q1 2026 in Review

195 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.

  • 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
  • Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
  • 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
  • The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2026.